Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii.
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii.
复制标题
DOI:
10.1073/pnas.2213116119
复制
发表时间:
2022-12-20
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Drug-resistant strains of Acinetobacter baumannii are increasingly prevalent leading to increased morbidity and mortality, thereby dictating the need for new classes of antibiotics. Herein, we provide genetic and chemical validation of the A. baumannii pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (AbDHODH) as a potential drug target to treat this infection. We showed that AbDHODH is essential for A. baumannii to survive within the host, and we identified potent, species-specific inhibitors of AbDHODH active against highly drug-resistant A. baumannii strains. One compound conferred significant protection to mice. Structural studies of inhibitor-bound AbDHODH defined the inhibitor-binding pocket. These data support the development of antimicrobial agents directed against AbDHODH for the treatment of infections due to drug-resistant A. baumannii. New antimicrobials are needed for the treatment of extensively drug-resistant Acinetobacter baumannii. The de novo pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) is a validated drug target for malaria and human autoimmune diseases. We provide genetic evidence that A. baumannii DHODH (AbDHODH) is essential for bacterial survival in rodent infection models. We chemically validate the target by repurposing a unique library of ~450 triazolopyrimidine/imidazopyrimidine analogs developed for our malaria DHODH program to identify 21 compounds with submicromolar activity on AbDHODH. The most potent (DSM186, DHODH IC50 28 nM) had a minimal inhibitory concentration of ≤1 µg/ml against geographically diverse A. baumannii strains, including meropenem-resistant isolates. A structurally related analog (DSM161) with a long in vivo half-life conferred significant protection in the neutropenic mouse thigh infection model. Encouragingly, the development of resistance to these compounds was not identified in vitro or in vivo. Lastly, the X-ray structure of AbDHODH bound to DSM186 was solved to 1.4 Å resolution. These data support the potential of AbDHODH as a drug target for the development of antimicrobials for the treatment of A. baumannii and potentially other high-risk bacterial infections.
登录
查看更多内容
影响因子:
7.3
作者:
Coteron, Jose M.;Marco, Maria;Esquivias, Jorge;Deng, Xiaoyi;White, Karen L.;White, John;Koltun, Maria;El Mazouni, Farah;Kokkonda, Sreekanth;Katneni, Kasiram;Bhamidipati, Ravi;Shackleford, David M.;Angulo-Barturen, Inigo;Ferrer, Santiago B.;Belen Jimenez-Diaz, Maria;Gamo, Francisco-Javier;Goldsmith, Elizabeth J.;Charman, William N.;Bathurst, Ian;Floyd, David;Matthews, David;Burrows, Jeremy N.;Rathod, Pradipsinh K.;Charman, Susan A.;Phillips, Margaret A.
通讯作者:
Phillips, Margaret A.
影响因子:
7.3
作者:
Marwaha, Alka;White, John;El Mazouni, Farah;Creason, Sharon A.;Kokkonda, Sreekanth;Buckner, Frederick S.;Charman, Susan A.;Phillips, Margaret A.;Rathod, Pradipsinh K.
通讯作者:
Rathod, Pradipsinh K.
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
DOI:
10.1016/s0969-2126(00)00077-0
发表时间:
2000-01-15
期刊:
STRUCTURE WITH FOLDING & DESIGN
影响因子:
--
作者:
Liu, SP;Neidhardt, EA;Clardy, J
通讯作者:
Clardy, J
影响因子:
7.3
作者:
Gujjar R;El Mazouni F;White KL;White J;Creason S;Shackleford DM;Deng X;Charman WN;Bathurst I;Burrows J;Floyd DM;Matthews D;Buckner FS;Charman SA;Phillips MA;Rathod PK
通讯作者:
Rathod PK